Pricing
Login
Home
Charts
Search
Watchlist
Products

Shukra Medtech Ltd

SHUKRAMED
₹84.1620 Nov 2026
Reports
Pharma Others

Shukra Medtech Ltd

SHUKRAMED
₹84.16
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹3,724Cr
Close
Close Price
₹84.16
Industry
Industry
Pharma Others
PE
Price To Earnings
82.51
PS
Price To Sales
32.91
Revenue
Revenue
₹113Cr
Rev Gr TTM
Revenue Growth TTM
222.24%
PAT Gr TTM
PAT Growth TTM
270.48%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1113563962444
Growth YoY
Revenue Growth YoY%
269.9-52.4336.4651.7
Expenses
ExpensesCr
7646126426
Operating Profit
Operating ProfitCr
47102711919
OPM
OPM%
37.255.224.5-7.169.311.181.442.3
Other Income
Other IncomeCr
11121111
Interest Expense
Interest ExpenseCr
00000000
Depreciation
DepreciationCr
11111111
PBT
PBTCr
48102701818
Tax
TaxCr
120-26255
PAT
PATCr
351220-21313
Growth YoY
PAT Growth YoY%
544.3-131.91,158.3434.0
NPM
NPM%
29.940.619.140.552.0-27.255.128.8
EPS
EPS₹
0.10.10.00.10.50.00.30.3
QuarterDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
1113563962444
Growth YoY
Revenue Growth YoY%
269.9-52.4336.4651.7
Expenses
ExpensesCr
7646126426
Operating Profit
Operating ProfitCr
47102711919
OPM
OPM%
37.255.224.5-7.169.311.181.442.3
Other Income
Other IncomeCr
11121111
Interest Expense
Interest ExpenseCr
00000000
Depreciation
DepreciationCr
11111111
PBT
PBTCr
48102701818
Tax
TaxCr
120-26255
PAT
PATCr
351220-21313
Growth YoY
PAT Growth YoY%
544.3-131.91,158.3434.0
NPM
NPM%
29.940.619.140.552.0-27.255.128.8
EPS
EPS₹
0.10.10.00.10.50.00.30.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
3357113
Growth
Revenue Growth%
74.0222.2
Expenses
ExpensesCr
202848
Operating Profit
Operating ProfitCr
132966
OPM
OPM%
39.150.658.0
Other Income
Other IncomeCr
453
Interest Expense
Interest ExpenseCr
111
Depreciation
DepreciationCr
334
PBT
PBTCr
132963
Tax
TaxCr
4719
PAT
PATCr
102244
Growth
PAT Growth%
130.3270.5
NPM
NPM%
29.438.939.1
EPS
EPS₹
0.20.51.0
Financial YearMar 2025Mar 2026TTM
Revenue
RevenueCr
3357113
Growth
Revenue Growth%
74.0222.2
Expenses
ExpensesCr
202848
Operating Profit
Operating ProfitCr
132966
OPM
OPM%
39.150.658.0
Other Income
Other IncomeCr
453
Interest Expense
Interest ExpenseCr
111
Depreciation
DepreciationCr
334
PBT
PBTCr
132963
Tax
TaxCr
4719
PAT
PATCr
102244
Growth
PAT Growth%
130.3270.5
NPM
NPM%
29.438.939.1
EPS
EPS₹
0.20.51.0
Sales CAGR
1 Year74%
3 Years-
5 Years-
TTM222%
EBITDA CAGR
1 Year126%
3 Years-
5 Years-
TTM440%
PAT CAGR
1 Year130%
3 Years-
5 Years-
TTM270%
Avg. ROCE
1 Year33%
3 Years-
5 Years-
TTM46%
CFO / EBITDA
1 Year11%
3 Years-
5 Years-
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
444444
Reserves
ReservesCr
194174
Current Liabilities
Current LiabilitiesCr
172346
Non Current Liabilities
Non Current LiabilitiesCr
7511
Total Liabilities
Total LiabilitiesCr
87117175
Current Assets
Current AssetsCr
6584128
Non Current Assets
Non Current AssetsCr
213447
Total Assets
Total AssetsCr
87117175
Financial YearMar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
444444
Reserves
ReservesCr
194174
Current Liabilities
Current LiabilitiesCr
172346
Non Current Liabilities
Non Current LiabilitiesCr
7511
Total Liabilities
Total LiabilitiesCr
87117175
Current Assets
Current AssetsCr
6584128
Non Current Assets
Non Current AssetsCr
213447
Total Assets
Total AssetsCr
87117175

Cash Flow

Consolidated
Standalone
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
83
Investing Cash Flow
Investing Cash FlowCr
-1-14
Financing Cash Flow
Financing Cash FlowCr
-55
Net Cash Flow
Net Cash FlowCr
2-6
Free Cash Flow
Free Cash FlowCr
5-13
CFO To PAT
CFO To PAT%
82.714.3
CFO To EBITDA
CFO To EBITDA%
62.211.0
Financial YearMar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
83
Investing Cash Flow
Investing Cash FlowCr
-1-14
Financing Cash Flow
Financing Cash FlowCr
-55
Net Cash Flow
Net Cash FlowCr
2-6
Free Cash Flow
Free Cash FlowCr
5-13
CFO To PAT
CFO To PAT%
82.714.3
CFO To EBITDA
CFO To EBITDA%
62.211.0

Ratios

Consolidated
Standalone
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9571,3293,724
Price To Earnings
Price To Earnings
99.360.782.5
Price To Sales
Price To Sales
29.423.432.9
Price To Book
Price To Book
15.215.729.8
EV To EBITDA
EV To EBITDA
74.546.256.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
75.172.072.0
OPM
OPM%
39.150.658.0
NPM
NPM%
29.438.939.1
ROCE
ROCE%
20.833.445.7
ROE
ROE%
15.226.137.4
ROA
ROA%
11.018.825.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
9571,3293,724
Price To Earnings
Price To Earnings
99.360.782.5
Price To Sales
Price To Sales
29.423.432.9
Price To Book
Price To Book
15.215.729.8
EV To EBITDA
EV To EBITDA
74.546.256.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
75.172.072.0
OPM
OPM%
39.150.658.0
NPM
NPM%
29.438.939.1
ROCE
ROCE%
20.833.445.7
ROE
ROE%
15.226.137.4
ROA
ROA%
11.018.825.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr6,1713,7243,3022,0592,0581,569963
Close PriceClose₹190.1684.16468.9521.90335.951,110.15817.60
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE3.7782.519.7421.68111.615.6719.57
Price To SalesPS3.1932.911.393.972.851.710.90
RevenueRevenueCr1,9321132,3695187219181,068
Revenue Growth TTMRev Gr TTM%3,141.0%222.2%6.4%0.6%19.4%11.3%42.7%
PAT Growth TTMPAT Gr TTM%712.6%270.5%283.1%51.6%323.7%317.3%16.8%
Market CapitalizationMkt CapCr6,1713,7243,3022,0592,0581,569963
Close PriceClose₹190.1684.16468.9521.90335.951,110.15817.60
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE3.7782.519.7421.68111.615.6719.57
Price To SalesPS3.1932.911.393.972.851.710.90
RevenueRevenueCr1,9321132,3695187219181,068
Revenue Growth TTMRev Gr TTM%3,141.0%222.2%6.4%0.6%19.4%11.3%42.7%
PAT Growth TTMPAT Gr TTM%712.6%270.5%283.1%51.6%323.7%317.3%16.8%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Load More
Interviews